2025/26 Deal-Making Highlights: How Did They Happen?

• Representing examples of successful deal-making and successful management of alliances to foster future deals, what are the learnings?
• Sharing how early-stage programs can successfully navigate the “show me data” barrier with pharma, and the activation barrier to licencing technologies between equal sized biotech
• Debating recent regulatory and emerging technology shifts, and how these will shape licensing deals for the discussed modalities

Speakers:

John Mayfield

Chief Executive Officer

JEO Biotech Advisors

Isabel Chiu

Senior Vice President

C4 Therapeutics

Fei Shen

Head of BD&L USA & Global TA Inflammation

Boehringer Ingelheim

John Flygare

Head of Large Molecule & ADC Innovation

Eli Lilly & Co.

Michael Torres

Former - Chief Executive Officer

CrossBridge Bio

Stephan Lensky

President, Chief Operating & Business Officer

Epimab Biotherapeutics